{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:12:48Z","timestamp":1780445568981,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004061","name":"Austrian National Bank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dr. Karl Josef Hier and the Peter Goop Stiftung"},{"name":"Fachhochschule Dornbirn"},{"name":"Academic Teaching Hospital Feldkirch"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jdiacomp.2020.107692","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T22:00:06Z","timestamp":1595887206000},"page":"107692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Type 2 diabetes mellitus is a strong predictor of LDL cholesterol target achievement in patients with peripheral artery disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Christoph H.","family":"Saely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Sternbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Vonbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Heinzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Zanolin-Purin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Larcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Leiherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Muendlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2020.107692_bb0005","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0015","author":"Aboyans","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0020","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0035","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0040","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0045","first-page":"1","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0050","article-title":"Lipid-lowering for peripheral arterial disease of the lower limb","volume":"4","author":"Aung","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0055","doi-asserted-by":"crossref","first-page":"w13828","DOI":"10.4414\/smw.2013.13828","article-title":"Current cholesterol guidelines and clinical reality: a comparison of two cohorts of coronary artery disease patients","volume":"143","author":"Vonbank","year":"2013","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2018.02.013","article-title":"Poor attainment of lipid targets in patients with symptomatic peripheral artery disease","author":"Dopheide","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0065","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.amjcard.2010.11.006","article-title":"Achieving optimal lipid goals in patients with coronary artery disease","volume":"107","author":"Karalis","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0070","first-page":"2473","article-title":"Comprehensive efforts to increase adherence to statin therapy","volume":"38","author":"Vonbank","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacl.2013.03.001","article-title":"Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education","volume":"7","author":"Wei","year":"2013","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2017.11.020","article-title":"Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: real-world evidence from Germany","volume":"268","author":"M\u00e4rz","year":"2018","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2016.07.001","article-title":"Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: an analysis of more than 33,000 high cardiovascular risk patients in Japan","volume":"251","author":"Teramoto","year":"2016","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2019.03.017","article-title":"Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: analysis of a large real practice database in Italy","volume":"285","author":"Presta","year":"2019","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.atherosclerosis.2018.02.024","article-title":"Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: insights from Italian general practice","volume":"271","author":"Arca","year":"2018","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2019.03.014","article-title":"Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries","volume":"285","author":"De Backer","year":"2019","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0105","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0110","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0115","series-title":"FDA drug safety communication: new restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury","year":"2019"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0120","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1177\/2047487318806359","article-title":"Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: results from DYSIS II Europe","volume":"25","author":"Ferrieres","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0125","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.acvd.2017.07.007","article-title":"Reaching low-density lipoprotein cholesterol treatment targets in stable coronary artery disease: determinants and prognostic impact","volume":"111","author":"Bauters","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.108.838466","article-title":"Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals","volume":"120","author":"Waters","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0135","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.clinthera.2017.03.001","article-title":"Use of lipid-modifying therapy and LDL-C goal attainment in a high-cardiovascular-risk population in the Netherlands","volume":"39","author":"Kuiper","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0140","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Statins have a dose-dependent effect on amputation and survival in peripheral artery disease patients","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications","volume":"26","author":"Dal Canto","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0150","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijcard.2009.04.048","article-title":"Low serum LDL cholesterol in patients with type 2 diabetes: an analysis on two different patient populations","volume":"144","author":"Saely","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/diacare.28.1.101","article-title":"Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?","volume":"28","author":"Drexel","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2020.107692_bb0170","doi-asserted-by":"crossref","DOI":"10.2337\/dc08-2015","article-title":"Ankle-to-brachial ratio index underestimates the prevalence of peripheral occlusive disease in diabetic patients at high risk for arterial disease","volume":"32","author":"Potier","year":"2009","journal-title":"Diabetes Care"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872720304542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872720304542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:11:16Z","timestamp":1761005476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872720304542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1056872720304542"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107692","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes mellitus is a strong predictor of LDL cholesterol target achievement in patients with peripheral artery disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107692","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107692"}}